Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorJESTIN-GUYON, Nolwenn
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorOUAALAYA, El Hassane
dc.contributor.authorBERNADY, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBERTEAUD, Emilie
dc.contributor.authorCASTEIGT, J.
dc.contributor.authorFALQUE, L.
dc.contributor.authorLE GUILLOU, F.
dc.contributor.authorMOINARD, J.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOLIMARD, Mathieu
dc.contributor.authorNGUYEN, L.
dc.contributor.authorNOCENT, C.
dc.contributor.authorOZIER, A.
dc.contributor.authorSTAALI, M.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.date.accessioned2024-05-15T07:47:07Z
dc.date.available2024-05-15T07:47:07Z
dc.date.issued2023-05-01
dc.date.conference2022-09-04
dc.identifier.issn1073-449Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/199844
dc.description.abstractEnBackground: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of mortality worldwide and its prevalence among women increased in the past decade in developed countries mainly due to tobacco consumption and other risk factors. This study investigates sex-related differences of FEV1 decline in a real-life cohort. Methods: Prospective multi-centered study of COPD patients recruited between 2013 and 2022. Information collected at inclusion and visits: smoking status, symptoms, clinical characteristics, comorbidities. The evolution of FEV1 was analyzed in patients with 2 or more measures. Results: 3,228 patients were enrolled in the study. Women (36.5%) were younger, had lower BMI and were more current smokers than men patients (p<0.001). Regarding symptoms women had more dyspnea (p<0.009) and exacerbations (p<0.001). No sex differences were found for chest tightness and cough, except for more expectorations among men (p<0.004). For comorbidities men had more hypertension, ischemic heart disease, diabetes and less anxiety, depression, osteoporosis and asthma (p<0.001). Men had a lower predicted FEV1 (57.4%) than women (60.5%) (p<0.001) and a more severe COPD according to GOLD classification (p=0.005). No sex-related differences was observed for FEV1 decline. Conclusion: This study demonstrates differences on characteristics and some clinical aspects of women and men with COPD.
dc.language.isoENen_US
dc.title.enSex-related Differences, Mortality and FEV1 Decline Among COPD Patients: The French Palomb Cohort
dc.typeCommunication dans un congrèsen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.page1en_US
bordeaux.volume207en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.conference.titleERS International Congress 2022en_US
bordeaux.countryesen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.teamEPICENE_BPHen_US
bordeaux.conference.cityBarceloneen_US
hal.identifierhal-04575620
hal.version1
hal.date.transferred2024-05-15T07:47:10Z
hal.proceedingsouien_US
hal.conference.organizerEuropean Respiratory Society (ERS)en_US
hal.conference.end2022-09-06
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.date=2023-05-01&amp;rft.volume=207&amp;rft.spage=1&amp;rft.epage=1&amp;rft.eissn=1073-449X&amp;rft.issn=1073-449X&amp;rft.au=JESTIN-GUYON,%20Nolwenn&amp;OUAALAYA,%20El%20Hassane&amp;BERNADY,%20A.&amp;BERTEAUD,%20Emilie&amp;CASTEIGT,%20J.&amp;rft.genre=unknown


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem